172@29@16@57!~!172@29@0@53!~!|company-article|cadilahealth|news|CHC!~!www|moneycontrol|com!~!|stocks|company_info|stock_news.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 26, 16:00
417.35
-6.5 (-1.53%)
VOLUME 107,912
LIVE
NSE
Oct 26, 15:54
418.85
-5.45 (-1.28%)
VOLUME 2,709,889
News on Cadila Healthcare
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila Healthcare share price rises 2% post USFDA approval

12.00 pm | 23 Oct 2020 |  Source: Moneycontrol.com

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad....

Traders can opt for buy-on-dip strategy till Nifty trades above 11,500

11.58 am | 19 Oct 2020 |  Source: Moneycontrol.com

The index has given bullish crossover as 100 DMA crossed 200 DMA from below, signaling that the strong bullish momentum will continue in the mid term....

COVID-19: Even as domestic demand for Remdesivir outstrips supply, manufacturers are exporting the drug

3.17 pm | 29 Sep 2020 |  Source: Moneycontrol.com

One drug company executive says as per the licensing agreement with Gilead, companies will have to cater to 127 countries. Gilead has signed deals wit...

Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug

11.21 am | 25 Sep 2020 |  Source: PTI

Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed release capsu...

Cadila: a formidable play in Covid times and beyond

9.39 am | 25 Sep 2020 |  Source: Moneycontrol.com

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space w...

Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

10.55 am | 24 Sep 2020 |  Source: PTI

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg...

Cadila Healthcare in talks with RDIF to bring COVID-19 vaccine to India; shares hit 52-week high

11.35 am | 18 Sep 2020 |  Source: Moneycontrol.com

RDIF has agreed to supply 10 crore doses of the world’s first coronavirus vaccine to Dr Reddy’s Laboratories. However, it wanted to scale up the s...

Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

5.05 pm | 17 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended reduce rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 14, 2020....

Buy Cadila Healthcare; target of Rs 470: ICICI Direct

1.00 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August...

Accumulate Cadila Healthcare; target of Rs 408: Dolat Capital

9.16 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended accumulate rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 05, 2020....

Hold Cadila Healthcare; target of Rs 402: Emkay Global Financial

2.43 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Cadila Healthcare with a target price of Rs 402 in its research report dated August 05, 2020....

Sell Cadila Healthcare; target of Rs 329: Prabhudas Lilladher

12.34 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 329 in its research report date...

Hold Cadila Healthcare; target of Rs 445: Sharekhan

2.13 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Cadila Healthcare with a target price of Rs 445 in its research report dated August 05, 2020....

Buy Cadila Healthcare; target of Rs 460: Motilal Oswal

2.02 pm | 07 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 460 in its research report dated August 06...

Cadila Health Consolidated June 2020 Net Sales at Rs 3,639.90 crore, up 4.11% Y-o-Y

7.11 pm | 05 Aug 2020 |  Source: Moneycontrol.com

NULL...

Cadila Health Standalone June 2020 Net Sales at Rs 1,795.90 crore, up 33.64% Y-o-Y

7.11 pm | 05 Aug 2020 |  Source: Moneycontrol.com

NULL...

Buy Cadila Healthcare; target of Rs 420: ICICI Direct

6.12 pm | 23 Jun 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June 2...

Cadila Health Standalone March 2020 Net Sales at Rs 1,812.20 crore, up 15.43% Y-o-Y

9.06 am | 22 Jun 2020 |  Source: Moneycontrol.com

NULL...

Cadila Health Consolidated March 2020 Net Sales at Rs 3,752.10 crore, up 0.52% Y-o-Y

9.01 am | 22 Jun 2020 |  Source: Moneycontrol.com

NULL...

Buy Cadila Healthcare; target of Rs 420: Motilal Oswal

7.48 am | 22 Jun 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 420 in its research report dated June ...

1 2
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.